Optimization of high-throughput autoantibody profiling for the discovery of novel antigenic targets in rheumatoid arthritis

Annals of the New York Academy of Sciences

Volumn 1173, Issue , 2009, Pages 92-102

  Somers, Klaartje ^a   Stinissen, Piet ^a   Somers, Veerle ^a  

^a HASSELT UNIVERSITY   (Belgium)

Author keywords

Autoantibody profiling; CDNA phage display; Multiplexing; Rheumatoid arthritis; Seronegative

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; BINDING PROTEIN; CALPASTATIN; CALRETICULIN; COMPLEMENTARY DNA; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; EPSTEIN BARR VIRUS ANTIGEN; FIBRIN; FIBRONECTIN; GLUCOSE 6 PHOSPHATE ISOMERASE; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; IMMUNOGLOBULIN G; RHEUMATOID FACTOR;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIGENICITY; B LYMPHOCYTE; CELL HETEROGENEITY; CONFERENCE PAPER; DIAGNOSTIC PROCEDURE; DISEASE MARKER; DNA LIBRARY; GENETIC ASSOCIATION; HIGH THROUGHPUT SCREENING; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PROCESS OPTIMIZATION; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS;

EID: 70049102387     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04654.x     Document Type: Conference Paper

References (34)

1. Kvien, T.K. 2004. Epidemiology and burden of illness of rheumatoid arthritis. Pharmacoeconomics 22: 1-12.
2. Vital, E.M. & P. Emery. 2008. The development of targeted therapies in rheumatoid arthritis. J. Autoim-mun. 31: 219-227.
3. Firestein, G.S. 2003. Evolving concepts of rheumatoid arthritis. Nature 423: 356-361.
4. Atzeni, F., A. Doria, T. Maurizio, et al. 2007. What is the role of rituximab in the treatment of rheumatoid arthritis? Autoimmun. Rev. 6: 553-558.
5. Bugatti, S., V. Codullo, R. Caporali, et al. 2007. B cells in rheumatoid arthritis. Autoimmun. Rev. 7: 137-142. (Pubitemid 350116726)
6. Van Der Helm-van Mil, A.H. & T.W. Huizinga. 2008. Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets. Arthritis Res. Ther. 10: 205.
7. Klareskog, L., J. Ronnelid, K. Lundberg, et al. 2008. Immunity to citrullinated proteins in rheumatoid arthritis. Annu. Rev. Immunol. 26: 651-675.
8. van Venrooij, W.J., J.J. van Beers & G.J. Pruijn. 2008. Anti-CCP Antibody, a Marker for the Early Detection of Rheumatoid Arthritis. Ann. N. Y. Acad. Sci. 1143: 268-285.
9. van Gaalen, F.A., S.P. Linn-Rasker, W.J. van Ven-rooij, et al. 2004. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum. 50: 709-715.
10. Machold, K.P., T.A. Stamm, V.P. Nell, et al. 2007. Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with ra-diographic progression over the first years of disease. Rheumatology (Oxford) 46: 342-349.
11. van Oosterhout, M., I. Bajema, E.W. Levarht, et al. 2008. Differences in synovial tissue infiltrates between anti-cyclic citrullinated peptide-positive rheumatoid arthritis and anti-cyclic citrulli-nated peptide-negative rheumatoid arthritis. Arthritis Rheum. 58: 53-60.
12. Blass, S., J.M. Engel & G.R. Burmester. 1999. The immunologic homunculus in rheumatoid arthritis. Arthritis Rheum. 42: 2499-2506.
13. Mewar, D. & A.G. Wilson. 2006. Autoantibodies in rheumatoid arthritis: a review. Biomed. Pharmacother. 60: 648-655.
14. van Boekel, M.A., E.R. Vossenaar, F.H. van den Hoogen, et al. 2002. Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res. 4: 87-93.
15. Magalhaes, R., P. Stiehl, L. Morawietz, et al. 2002. Morphological and molecular pathology of the B cell response in synovitis of rheumatoid arthritis. Virchows Arch. 441: 415-427.
16. Holmdahl, R. 2000. Experimental models for rheumatoid arthritis. In Rheumatoid Arthritis: New Frontiers in Pathogenesis and Treatment. G.S. Firestein, G.S. Panayi & F.A. Wollheim, Eds.: 39-51. Oxford University Press. New York, NY.
17. Waaler, E. 2007. On the occurrence of a factor in human serum activating the specific agglutintion of sheep blood corpuscles. 1939. APMIS 115: 422-438.
18. Nishimura, K., D. Sugiyama, Y. Kogata, et al. 2007. Meta-analysis: diagnostic accuracy of anti-cyclic cit-rullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann. Intern. Med. 146: 797-808.
19. Cantaert, T., L. De Rycke, T. Bongartz, et al. 2006. Citrullinated proteins in rheumatoid arthritis: crucial. . .but not sufficient! Arthritis Rheum. 54: 3381-3389.
20. van Venrooij, W.J., A.J. Zendman & G.J. Pruijn. 2006. Autoantibodies to citrullinated antigens in (early) rheumatoid arthritis. Autoimmun. Rev. 6: 37-41.
21. Hueber, W., B.A. Kidd, B.H. Tomooka, et al. 2005. Antigen microarray profiling of autoantibod-ies in rheumatoid arthritis. Arthritis Rheum. 52: 2645-2655.
22. Scott, J.K. & G.P. Smith. 1990. Searching for peptide ligands with an epitope library. Science 249: 386-390.
23. Sioud, M., O. Forre & A. Dybwad. 1996. Selection of ligands for polyclonal antibodies from random peptide libraries: potential identification of (auto)antigens that may trigger B and T cell responses in autoimmune diseases. Clin. Immunol. Immunopathol. 79: 105-114.
24. Cortese, I., S. Capone, S. Luchetti, et al. 2001. Cross-reactive phage-displayed mimotopes lead to the discovery of mimicry between HSV-1 and a brain-specific protein. J. Neuroimmunol. 113: 119-128.
25. Hufton, S.E., P.T. Moerkerk, E.V. Meulemans, et al. 1999. Phage display of cDNA repertoires: the pVI display system and its applications for the selection of immunogenic ligands. J. Immunol. Methods 231: 39-51.
26. Mewar, D., D.J. Moore, S. Young-Min, et al. 2005. Antiferritin antibodies discovered by phage display expression cloning are associated with radiographic damage in rheumatoid arthritis. Arthritis Rheum. 52: 3868-3872.
27. Niwa, M., K. Fukuoka, T. Fujimoto, et al. 2004. Efficient isolation of cDNA clones encoding rheumatoid arthritis autoantigens by lambda phage surface display. J. Biotechnol. 114: 55-58.
28. Somers, V., C. Govarts, K. Somers, et al. 2008. Au-toantibody profiling in multiple sclerosis reveals novel antigenic candidates. J. Immunol. 180: 3957-3963.
29. Cleutjens, K.B., B.C. Faber, M. Rousch, et al. 2008. Noninvasive diagnosis of ruptured peripheral atherosclerotic lesions and myocardial infarction by antibody profiling. J. Clin. Invest. 118: 2979-2985.
30. Cortese, I., R. Tafi, L.M. Grimaldi, et al. 1996. Identification of peptides specific for cerebrospinal fluid antibodies in multiple sclerosis by using phage libraries. Proc. Natl. Acad. Sci. USA 93: 11063-11067.
31. Avrameas, S., T. Ternynck, I.A. Tsonis, et al. 2007. Naturally occurring B-cell autoreactivity: a critical overview. J. Autoimmun. 29: 213-218.
32. Somers, V.A., R.J. Brandwijk, B. Joosten, et al. 2002. A panel of candidate tumor antigens in colorectal cancer revealed by the serological selection of a phage displayed cDNA expression library. J. Immunol. 169: 2772-2780.
33. Govarts, C., K. Somers, R. Hupperts, et al. 2007. Exploring cDNA phage display for autoantibody profiling in the serum of multiple sclerosis patients: optimization of the selection procedure. Ann. N. Y. Acad. Sci. 1109: 372-384.
34. Briantais, M.J., L. Grangeot-Keros & J. Pillot. 1984. Specificity and sensitivity of the IgM capture im-munoassay: studies of possible factors inducing false positive or false negative results. J. Virol. Methods 9: 15-26.